Opthea Limited (NASDAQ:OPT), a biotechnology company specializing in the development of novel therapeutics for eye diseases, announced today that it will participate in the Oppenheimer Healthcare ...
H&R Block (NYSE:HRB) reported a wider-than-expected loss for the second quarter of fiscal 2024, missing analysts' forecasts. The company's stock fell 2.49% in after-hours trading following the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback